Comparison of Low-Dose Rosuvastatin with Atorvastatin in Lipid-Lowering Efficacy and Safety in a High-Risk Pakistani Cohort: An Open-Label Randomized Trial

Table 2

Underlying diagnosis.

Disease	Atorvastatin group; (𝑛=63)	Rosuvastatin group; (𝑛=66)
Diabetes mellitus	53	44
Essential hypertension	27	24
Effort angina	4	7
Congestive heart failure	2	4
MI in past	1	3
Stroke in past	2	3

Figures refer to the number of patients. Many patients had more than one diagnosis.